Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer: Phase II study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 4, 2003, Pages 363-365

  Mohedano Mohedano, Nicolás ^a   Sánchez Rovira, Pedro ^b   Lozano Barriuso, Ana ^b   Fernandez Morales, Margarita ^b   Medina Magan, Begoña ^b   Jaen Morago, Ana ^b   Porras Quintela, Ignacio ^b   Dueñas Garcia, Rosario ^b   Fernandez Flores, Encarna ^b   Moreno Moreno, Miguel Angel ^b  

^a Hosp Univ Ciudad de Jaén   (Spain)

^b NONE

Author keywords

Chemotherapy; Cisplatin; Gemcitabine; Ifosfamide; Non small cell lung cancer; Phase II trial

Indexed keywords

CISPLATIN; GEMCITABINE; IFOSFAMIDE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTOPENIA; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OUTPATIENT CARE; PHASE 2 CLINICAL TRIAL; RASH; THROMBOCYTOPENIA; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 10744224298     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.COC.0000026480.71889.F3     Document Type: Article

References (18)

1. Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer - report of a Canadian multicenter randomized trial. J Clin Oncol 1988;6:633-41.
2. Bunn PA Jr. The expanding role of cisplatin in the treatment of non-small-cell lung cancer. Semin Oncol 1989;16(suppl 6):10-22.
3. Souqurt PJ, Chauvin F, Boissel JP, et al. Polychemotherapy in advanced non-small-cell lung cancer: a meta-analysis. Lancet 1993;342:19-21.
4. Chevalier TL. Chemotherapy for advanced NSCLC - will metaanalysis provide the answer? Chest 1996;109:107-9S.
5. American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 1997;15:2996-3018.
6. Krigel RL, Palackdharry CS, Padavic K, et al. Ifosfamide, carboplatin and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer. J Clin Oncol 1994;12:1251.
7. Bunn PA. Triplet chemotherapy combinations with new agents: Is there a rationale? Semin Oncol 1988;25(suppl 9):55-61.
8. Anderson H, Lund B, Bach F, et al. Single agent activity of weekly gemcitabine in advanced non-small cell lung cancer: a phase II study. J Clin Oncol 1994;12:1535-40.
9. Abratt RP, Bezwoda WR, Falkson G, et al. Efficacy and safety profile of gemcitabine in non-small cell lung cancer: a phase II study. J Clin Oncol 1994;12:1535-40.
10. Tonato M, Mosconi AM, Martin C. A safety profile of gemcitabine. Anticancer Drugs 1995;6(suppl 10):27-32.
11. Green MR. Gemcitabine safety overview. Semin Oncol 1996;23(suppl 10):32-5.
12. Van Moorsel CJ, Veerman G, Kuiper CM, et al. Mechanism of synergism between gemcitabine and cisplatin in ovarian and non-small-cell lung cancer lines. Cancer Res 1996;37:25-37.
13. Crinò L, Scagliotti G, Marangolo M, et al. Cisplatin-gemcitabine combination in advanced non-small cell lung cancer: a phase II study. J Clin Oncol 1997;15:297-303.
14. Abratt RP, Bezwoda WR, Goedhals L, et al. Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small cell lung cancer. J Clin Oncol 1997;15:744-9.
15. Einhorn L. Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: a Hoosier Oncology Group study. Semin Oncol 1997;24(suppl 8):24-8.
16. Carmichael J, Allerheiligen S, Walling J. A phase study of gemcitabine and carboplatin in non-small cell lung cancer. Semin Oncol 1996;23(suppl 10):55-9.
17. Carmichael J, Langley R, Osbourne L, et al. A phase I study to investigate alternate sequencing of the combination gemcitabine followed by carboplatin in NSCLC [Abstract 1042]. Eur J Cancer 1997;33(suppl 8):230.
18. Cardenal F, Rosell R, Anton A, et al. Gemcitabine plus cisplatin versus etoposide in advanced non-small cell lung cancer patients: preliminary randomized phase III results [Abstract]. Proc Am Soc Clin Oncol 1997;16:458.